Halozyme Therapeutics (HALO) Announces Global Collaboration and License Agreement With GSK

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best healthcare stocks to buy for the long term. Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced on May 7 that the company entered into a global collaboration and license agreement with GSK, under which GSK has licensed Halozyme’s ENHANZE® drug delivery technology for the development and potential commercialization of subcutaneous administration of multiple oncology targets. This includes antibody drug conjugates (ADCs), as well as an option for additional future drug targets.

Is Halozyme Therapeutics, Inc. (HALO) the Unstoppable Growth Stock to Invest in Now?

Eric Richards, SVP Head of Medicine Development Leaders Oncology, GSK, said that they “see significant potential for subcutaneous formulations of several promising cancer targets, including ADCs, with ENHANZE and look forward to progressing the first clinical program”.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) further reported that GSK will make an upfront payment to Halozyme and potential future milestone payments, and Halozyme will also be entitled to royalties on net sales of products that incorporate ENHANZE®. In a separate development, H.C. Wainwright lifted the price target on Halozyme Therapeutics, Inc. (NASDAQ:HALO) to $95 from $90 on April 29, maintaining a Buy rating on the shares.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical technology platform company that develops, manufactures, and commercializes drug-device combination products through advanced auto-injector technology. They offer commercial or functional benefits, including increased patient comfort and adherence, and enhanced tolerability and convenience.

While we acknowledge the risk and potential of HALO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HALO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.